Directed Evolution of Iridium-Substituted Myoglobin Affords Versatile Artificial Metalloenzymes for Enantioselective C−C Bond-Forming Reactions by Ward, Thomas R.
–1–	
	
Highlight	
	
Directed	Evolution	of	Iridium-Substituted	Myoglobin	Affords	Versatile	
Artificial	Metalloenzymes	for	Enantioselective	C–C	Bond-Forming	
Reactions	Thomas	R.	Ward		Department	of	Chemistry	University	of	Basel,	Spitalstrasse	51	CH-4051	Basel,	Switzerland	email:	thomas.ward@unibas.ch			
Abstract	The	group	of	Hartwig	and	coworkers	recently	reported	on	a	versatile	metal-substitution	 strategy	 applied	 to	 natural	 heme	 proteins	 that	 beautifully	complements	 the	 more	 traditional	 approaches	 pursued	 for	 the	 creation	 of	artificial	metalloenzymes.	Herein	we	highlight	 the	novelty	of	 this	approach	and	set	it	into	the	broad	context	of	artificial	metalloenzymes.		In	 the	 past	 decade,	 artificial	metalloenzymes	 (ArMs)	 have	 attracted	 increasing	attention	 as	 alternative	 to	 the	 more	 traditional	 homogeneous	 catalysts	 and	enzymes.[1,	 2]	 Such	 ArMs	 result	 from	 the	 incorporation	 of	 an	 abiotic	 metal	cofactor	 within	 a	 host	 protein.	 Until	 recently,	 three	 complementary	 strategies	had	successfully	been	pursued	 for	 the	assembly	of	ArMs:	 i)	Covalent	anchoring	whereby	 the	 ligand	 bound	 to	 the	 metal	 is	 covalently	 linked	 to	 the	 protein	(Scheme	 1a)[3]	 ii)	 Supramolecular	 anchoring	 which	 relies	 on	 an	 high	 affinity	interaction	between	a	host	protein	and	its	guest	(or	inhibitor)	(Scheme	1b)[4]	and	iii)	Dative	anchoring	whereby	amino	acid	side-chains	bind	and	activate	a	metal	(Scheme	 1c).[5]	 The	 group	 of	 Hartwig	 and	 coworkers	 recently	 reported	 on	 a	versatile	 metal-substitution	 strategy	 applied	 to	 natural	 heme	 proteins	 that	beautifully	complements	these	three	approaches.[6]	ArMs	 combine	 attractive	 features	 of	 homogeneous	 catalysts	 and	 enzymes.	 The	cofactor	 can	 contain	 any	 element	 of	 the	 periodic	 table,	 thus	 significantly	expanding	 the	 accessible	 reaction	 repertoire	 of	 ArMs	 as	 compared	 to	 natural	biocatalysts.	 Furthermore,	 both	 chemical-	 and	 genetic	 optimization	 schemes	have	 successfully	 been	 applied	 to	 improve	 the	 performance	 of	 ArMs.[1,	 2]	However,	 the	 coinage	 metals,	 so	 dear	 to	 the	 organometallic	 community,	 are	frequently	inhibited	by	various	cellular	components,	including	glutathione.	As	a	consequence,	the	host	proteins	must	be	(partially)	purified	prior	to	the	addition	of	 the	abiotic	 cofactor,	 thus	 imposing	a	 significant	bottleneck	 towards	directed	evolution	schemes	that	typically	rely	on	screening	large	libraries	of	mutants.		
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Capitalizing	 on	 the	 planar	 structure	 of	 heme	 (iron-protoporphyrin	 IX	 Fe-PIX	hereafter),	Watanabe,	Lu	and	Hayashi	have	substituted	this	versatile	cofactor	by	a	variety	of	planar	polydentate	analogs	or	heme-derivatives	to	afford	ArMs	for	a	variety	of	transformations.	In	these	strategies	however,	most	of	the	optimization	effort	was	focused	on	chemical	modification	of	the	cofactor	rather	than	directed	evolution	of	the	host	protein	Scheme	2a.[7]	
	
	
	
Scheme	 1	 Selected	examples	of	directed	evolution	of	ArMs	based	upon:	 covalent	 anchoring	 to	azidophenylalanine	 engineered	 into	 Propyl	 OligoPeptidase	 (POP-ZA4)	 for	 enantioselective	cyclopropanation	a);	supramolecular	anchoring	based	on	the	biotin-streptavidin	technology	 for	
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enantioselective	 intermolecular	 C–H	 activation	 b)	 and	 dative	 anchoring	 of	 zinc	 in	 engineered	cytochrome	cb562	for	hydrolytic	reactions	c).	(Adapted	from	ref.	2	with	permission	from	Wiley)		Inspired	 by	 the	 isolobal	 analogy	 between	 the	 {Fe=O}-	 and	 the	 iron-carbene	 or	nitrene	 fragments,	 the	 groups	 of	 Arnold	 and	 later	 of	 Fasan	 repurposed	cytochrome	 P450s	 and	 myoglobin	 (Mb)	 to	 catalyse	 a	 variety	 of	 abiotic	transformations:	 enantioselective	 cyclopropanation,[9,	 10]	 nitrene	 insertion	 etc.	Scheme	2	b,	c.[2,	8]		In	stark	contrast	to	ArMs,	such	repurposed	enzymes	are	fully	compatible	with	 cellular	 components	 and	 can	 thus	be	 screened	and	evolved	 in	
vivo	or	 in	cell	 lysates.	This	elegant	strategy	 is	 thus	only	 limited	by	 the	 intrinsic	reactivity	 of	 the	 Fe-PIX	 cofactor,	 augmented	 by	 the	 fine-tuning	 	 achieved	 via	genetic	means.		
	
	
	
Scheme	2	Repurposing	heme-containing	proteins	for	novel	transformations:	C–H	hydroxylation	relying	on	porphycene-reconstituted	myoglobin	MPc	·	Mb	a);	cyclopropanation	for	the	synthesis	of	a	levomilnacipran	precursor	relying	on	cytochrome	P450BM3	bearing	an	axial	histidine	C400H	
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b)	 and	 regioselective	 nitrene	 insertion	 relying	 on	 cytochrome	 P411BM3	bearing	 an	 axial	 serine	C400S	c);	cyclopropanation	of	styrene	derivatives	based	on	myoglobin	mutants	d)	(Adapted	from	ref.	2	with	permission	from	Wiley).		To	 capitalize	 on	 the	 versatile	 chemistry	 of	 precious	 metal	 porphyrins,	 the	Hartwig	 	 group	 recently	 reported	 on	 a	 metal-substitution	 strategy	 applied	 to	heme-proteins.[6]		Substitution	of	iron	in	protoporphyrin	IX	(Fe-PIX)	by	a	variety	of	metals	(M-PIX)	allowed	them	to	create	and	evolve	artificial	metalloenzymes	for	enantioselective	C–C	bond	 forming	reactions.	Reaction	of	a	diazoalkanoate	with	 (M-PIX)	affords	the	 corresponding	 (RO2CR'=M-PIX).	 If	 the	 substrate	 possesses	 an	 ortho-alkylether	 moiety,	 an	 intramolecular	 C–H	 insertion	 occurs	 to	 afford	 the	corresponding	enantioenriched	dihydrobenzofurans,	Scheme	3a.		Addition	of	an	alkene	 to	 (RO2CR'=M-PIX)	 leads	 to	 the	 formation	 of	 enantio-	 and	diastereoenriched	cyclopropanes,	Scheme	3b.	Exploratory	 screens	 resulting	 from	 varying	 the	 metal	 moiety	 as	 well	 as	 the	hemoprotein	 lead	 to	 the	 identification	 of	 {IrMe}	 and	 myoglobin	 as	 the	 most	promising	 combination.	 Genetic	 optimization	 of	 the	 catalytic	 performance	was	undertaken	next.	The	proximal	His93,	originally	bound	 to	Fe-PIX	was	mutated,	introducing	 either	 coordinating	 or	 non-coordinating	 amino	 acids.	 This	 lead	 to	the	 identification	 of	 His93Ala	 and	 His93Gly	 as	 the	 most	 promising	 mutants.	Subsequent	 rounds	 of	 iterative	 mutagenesis	 were	 aimed	 at	 tailoring	 the	substrate	 binding	 site	 above	 the	 porphyrin	 plane.	 For	 this	 purpose,	 the	 distal	His64	 as	 well	 as	 positions	 Leu32,	 Phe33,	 Phe43,	 Val68,	 His97	 and	 Ile99	were	mutated	with	a	 focused	 library	 including	hydrophobic	and	uncharged	residues.	In	 total,	 nearly	 five	 hundred	 (MeIr-PIX)	 ·	Mb	mutants	were	 screened.	 Selected	results	for	the	C–H	insertion	as	well	as	the	cyclopropanation	are	summarized	in	Scheme	3	a	and	b	respectively.	
	 	
Scheme	 3	 Iron	 substitution	 in	 myoglobin	 (Mb)	 by	 platinum	 group	 metals	 affords	 versatile	metalloenzymes	 (MeIr-PIX)	 ·	 Mb	 for	 C–C	 bond	 forming	 reactions	 a)	 and	 cyclopropanation	 of	challenging	substrates	b).			
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The	 contribution	 by	 Hartwig	 and	 coworkers	 presents	 several	 fascinating	features	which	are	highlighted	below.	i)	In	order	to	speed	up	the	screening	protocol,	ultimately	leading	to	the	directed	evolution	 of	 (MeIr-PIX)	 ·	 Mb,	 Escherichia	 coli	was	 grown	 under	 iron-depleted	conditions	 at	 low	 temperatures.	 This	 allowed	 the	 straightforward	 isolation	 of	apo-Mb	mutants,	which	were	 complemented	by	 the	metallated	M-PIX	 cofactor.	Parallel	 purification	 was	 achieved	 by	 affinity	 chromatography	 on	 a	 Ni(NTA)	column	(NTA	=	Nitrilotriacetate).	This	strategy	thus	allows	to	combine	the	rich	chemistry	 of	 abiological	 PIX	 variants	 with	 the	 power	 of	 directed	 evolution	 in	
vitro.		ii)	 Thanks	 to	 the	 position	 of	 the	 "artificial"	 cofactor	 (MeIr-PIX)	 within	myoglobin's	 natural	 active	 site,	 the	 abiotic	 substrate	 is	 completely	 embedded	within	a	protein	cavity.	This	contrasts	with	other	anchoring	strategies,	whereby	the	cofactor	is	often	more	exposed	to	the	solvent,	thus	offering	significantly	less	control	over	second	coordination	sphere	interactions	between	the	substrate	and	the	 host	 protein.[2-4]	 The	 use	 of	 focused	Mb-libraries,	 bearing	mutations	 in	 the	vicinity	 of	 (MeIr-PIX)	 cofactor,	 allowed	 to	 tailor	 the	 active	 site	 to	 catalyse	 two	enantioselective	 reactions,	 for	 which	 no	 known	 natural	 enzyme	 has	 been	reported	to	date.	iii)	Starting	from	an	active	but	an	essentially	non-selective	(MeIr-PIX)	 ·	WT-Mb	(WT	is	wildtype),	both	enantiomers	of	the	benzodihydrofuran	product	could	be	accessed	 by	 directed	 evolution.	 Importantly,	 up	 to	 >	 7’000	 turnovers	 could	 be	achieved.	 This	 highlights	 the	 versatility	 of	 the	 site	 isolation	 of	 the	 reactive	 Ir-carbene	 moiety,	 preventing	 catalyst	 deactivation.	 Screening	 the	 focused	 Mb	library	allowed	to	identify	promising		(MeIr-PIX)	·	Mb	for	a	variety	of	substrates:	the	 ester,	 the	 arene	 and	 the	 alkoxy	 functionality	 could	 all	 be	 varied	 affording	good	enantioselectivities	in	most	cases,	Scheme	3a.	iv)	Enantio-	and	diastereoselective	cyclopropanation	could	be	achieved	for	both	internal	 vinylarenes	 as	 well	 as	 unactivated	 alkenes.	 A	 key	 asset	 of	 the	optimization	 strategy	 relies	 on	 the	modularity	 of	 the	 approach	 since	 the	 same	(M-PIX)	·	Mb	mutant	library	can	be	screened	for	a	variety	of	different	reactions,	metals	and	substrates,	eventually	leading	to	the	identification	of	promising	ArMs	for	various	reactions,	Scheme	3b.	Although	 metal-substitution	 has	 been	 used	 in	 the	 past	 to	 generate	 artificial	metalloenzymes,	 their	 catalytic	 performance	 for	 new-to-nature	 reactions	 has	remained	limited.	This	contribution	unambiguously	demonstrates	the	versatility	of	this	strategy	to	create	and	evolve	ArMs	for	new-to-nature	reactions.	In	view	of	the	 vast	 number	 of	 heme-dependent	 proteins,	 this	 versatile	 approach	 offers	fascinating	opportunities	to	complement	other	ArM	strategies	(Scheme	1).	It	may	be	desirable	to	assemble	and	evolve	the	artficial	metalloenzymes	in	vivo	in	order	to	 screen	 significantly	 larger	 mutant	 libraries	 or	 to	 implement	 ArMs	 in	 the	context	of	synthetic	biology	applications.	This	in	vivo	applicability	is	an	essential	milestone	 toward	 new-to-nature	metabolism	 and	 remains	 to	 be	 demonstrated	for	the	noble	metal-containing	ArMs.	
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Catch-phrase:	Ugrading	myoglobin	with	iridium!	A	metal-substitution	strategy	affords	a	repurposed	myoglobin	for	challenging	cyclopropanation	and	intramolecular	C–H	activation	reactions.	The	performance	of	the	iridium-loaded	myoglobin	(orange	sphere)	was	improved	by	directed	evolution	of	eight	active	site	residues	(yellow	surface).		 	
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